FuturoLEAF(@FuturoLeaf) 's Twitter Profile Photo

Introduction of @FuturoLEAF partners: Cyano Biotech applies the artificial leaf concept as a novel platform for generation, optimization and of Next Gen ADC payloads for targeted cancer therapy. -drugconjugates

Introduction of @FuturoLEAF partners: Cyano Biotech applies the artificial leaf concept as a novel platform for generation, optimization and #industrialproduction of Next Gen ADC payloads for targeted cancer therapy.#researchproject #futuretechnologies #antibody-drugconjugates
account_circle
Sutura Therapeutics(@SuturaSci) 's Twitter Profile Photo

🧪 Meet Mavra Farooq: Scientist CMC at Sutura Therapeutics!

Specialising in Solid-Phase Peptide Synthesis (SPPS), Mavra optimises our drug conjugate platform with her expertise in peptide manufacturing.

🧪 Meet Mavra Farooq: Scientist CMC at Sutura Therapeutics!

Specialising in Solid-Phase Peptide Synthesis (SPPS), Mavra optimises our drug conjugate platform with her expertise in peptide manufacturing. 

#SuturaTherapeutics #DrugConjugates
account_circle
Sutura Therapeutics(@SuturaSci) 's Twitter Profile Photo

🌟 Excited for ? Join us as our CEO, Dr Edwin Wagena, presents Sutura's breakthroughs that could revolutionize healthcare. 🧬 Meet us at Convene, London, Apr 23-24. Let's shape biotech's future together! 🤝

🌟 Excited for #BioTrinity2024? Join us as our CEO, Dr Edwin Wagena, presents Sutura's breakthroughs that could revolutionize healthcare. 🧬 Meet us at Convene, London, Apr 23-24. Let's shape biotech's future together! 🤝

#SuturaTherapeutics #DrugConjugates
account_circle
Sutura Therapeutics(@SuturaSci) 's Twitter Profile Photo

A successful BioTrinity 2024 for Sutura! Dr. Edwin Wagena shared our breakthroughs in Rare Diseases R&D. Thanks to OBN_UK for a great event. Excited for future collaborations! 🧬

A successful BioTrinity 2024 for Sutura! Dr. Edwin Wagena shared our breakthroughs in Rare Diseases R&D. Thanks to @OBN_UK for a great event. Excited for future collaborations! 🧬 #BioTrinity2024 #SuturaTherapeutics #DrugConjugates #Biotechnology
account_circle
RedShiftBio(@redshiftbio) 's Twitter Profile Photo

Join us May 13, 2021 for an exciting webinar in collaboration with @TheUniversityofUtah to learn about Physicochemical Characterization of Labroots bit.ly/2PMrE7B

Join us May 13, 2021 for an exciting webinar in collaboration with @TheUniversityofUtah to learn about Physicochemical Characterization of #Antibody #DrugConjugates @Labroots bit.ly/2PMrE7B
account_circle
Pharmaceutics(@MDPIpharma) 's Twitter Profile Photo

, Synthesis and Characterization of pH-Sensitive Inulin Conjugate of Isoniazid for Monocyte- , mdpi.com/1999-4923/11/1…

This paper is from Special Issue 'Recent Developments in Polymer– ', mdpi.com/journal/pharma…

#mdpipharmaceutics, Synthesis and Characterization of pH-Sensitive Inulin Conjugate of Isoniazid for Monocyte-#Targeted #Delivery, mdpi.com/1999-4923/11/1…

This paper is from Special Issue 'Recent Developments in Polymer–#DrugConjugates', mdpi.com/journal/pharma…
account_circle
theaapsjournal(@theaapsjournal) 's Twitter Profile Photo

'Antibody Coadministration as a Strategy to Overcome Binding-Site Barrier for ADCs: a Quantitative Investigation”
| Dhaval K. Shah, State University of New York at Buffalo |
rdcu.be/b5vuj
-drugconjugates -vc-MMAE -PDmodel American Association of Pharmaceutical Scientists

'Antibody Coadministration as a Strategy to Overcome Binding-Site Barrier for ADCs: a Quantitative Investigation”
| Dhaval K. Shah, State University of New York at Buffalo | 
rdcu.be/b5vuj
#antibody-drugconjugates #Trastuzumab-vc-MMAE #PK-PDmodel #AAPSJ @AAPSComms
account_circle
Indian Pharma Post(@indpharmapost) 's Twitter Profile Photo

Antibody-drug conjugates gain traction in China oncology market, says GlobalData

indianpharmapost.com/news/antibody-…

-drugconjugates 

@Indianpharmapost

account_circle
Pharmaceuticals MDPI(@Pharmaceut_MDPI) 's Twitter Profile Photo

👏Quick reminder of by Louise Conilh et al. 'Exatecan Based on a Polysarcosine Drug-Linker Platform' that is available at:

👉mdpi.com/1424-8247/14/3…

👏Quick reminder of #HighlyCitedPaper by Louise Conilh et al. 'Exatecan #Antibody #DrugConjugates Based on a #Hydrophilic Polysarcosine Drug-Linker Platform' that is available at:

👉mdpi.com/1424-8247/14/3…
account_circle